Robert W. Georgantas
President at Providence Therapeutics, Inc.
Profile
Robert W.
Georgantas is currently the President & Chief Technology Officer at Providence Therapeutics, Inc. Prior to this, he was the Senior VP-Research & Translational Science at Biodesix, Inc. He holds a doctorate degree from The Johns Hopkins University School of Medicine.
Robert W. Georgantas active positions
| Companies | Position | Start |
|---|---|---|
Providence Therapeutics, Inc.
 Providence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Providence Therapeutics, Inc. operates as biotechnology company. The company is headquartered in Calgary, Canada. | President | 2023-01-31 |
Former positions of Robert W. Georgantas
| Companies | Position | End |
|---|---|---|
| BIODESIX, INC. | Corporate Officer/Principal | 2023-01-31 |
Training of Robert W. Georgantas
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIODESIX, INC. | Health Services |
| Private companies | 1 |
|---|---|
Providence Therapeutics, Inc.
Providence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Providence Therapeutics, Inc. operates as biotechnology company. The company is headquartered in Calgary, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert W. Georgantas
